Heavy plans have been introduced one after another, and the output value of this golden track is nearly 5 trillion! There are only 20 consecutive high-growth stocks, and half of the stocks have a price-earnings ratio of less than 30 times

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000661 002332 300122 300158 300181 300529 300595 300639 300713 Changchun High & New Technology Industry Chongqing Zhifei Biological Products Guangdong Hybribio Biotech Jafron Biomedical Ovctek China Shanxi Zhendong Pharmaceutical Shenzhenrease Technology Zhangzhou Pientzehuang Pharmaceutical Zhejiang Jolly Pharmaceutical Zhejiang Xianju Pharmaceutical Science, Technology Earnings Annual, Special Corporate Meeting Research, Development Agriculture Health, Beauty Product Pharmaceutical Computing, Information Technology Energy, Resource Manufacturing, Engineering Economy Market, Exchange Stocks Cancer Medicine Trend Biotechnology Pharmacology Biology Economics Technology, Engineering Information Technology, Computer Science Athletics, Track, Field Economy, Business, Finance Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Heavy plans have been introduced one after another, and the output value of this golden track is nearly 5 trillion! There are only 20 consecutive high-growth stocks, and half of the stocks have a price-earnings ratio of less than 30 times